South Korea approves human trial for Genexine’s coronavirus treatment drug


South Korean biotech firm Genexine Inc has received regulatory approval for a Phase I human clinical trial of its experimental coronavirus treatment drug, the Ministry of Food and Drug Safety said on Friday.

Genexine has separately said it was conducting the Phase I trial of its coronavirus vaccine on 60 participants in South Korea and plans to announce its results in October.

Was it worth reading? Let us know.